Top Markets
#1 Cortex Cortex +32.71%
#2 MarsCoin MarsCoin +11.83%
#3 Akedo Akedo +10.20%
#4 EXOD EXOD +9.04%
#5 龙虾 (Lobster) 龙虾 (Lobster) +8.94%
#6 Solstice Solstice +8.19%
#7 Pons Pons +8.06%
#8 The Black Bull The Black Bull +7.77%
#9 peaq peaq +7.29%
#10 Peapods Finance Peapods Finance +6.22%
Coin of the day
Cortex Cortex
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Damora Therapeutics, Inc. Damora Therapeutics, Inc.

Damora Therapeutics, Inc.

DMRA
Classifica tra le azioni #6698
Galecto, Inc. is a clinical-stage biotechnology company dedicated to pioneering... Galecto, Inc. is a clinical-stage biotechnology company dedicated to pioneering innovative small molecule therapeutics. These treatments are specifically engineered to address core biological pathways implicated in both cancer and fibrotic disorders. The firm is also actively developing small molecule inhibitors targeting galectin-3 and LOXL2. Established in 2011 by Ulf Jörgen Nilsson, Hakon Leffler, Tariq Sethi, and Hans Thalsgård Schambye, its corporate operations are based in Boston, Massachusetts.
Prezzo delle azioni
$30.90
Ultima sincronizzazione: 2026-08-27
Capitalizzazione di mercato
$1.90B
Variazione (1 giorno)
1.68%
Variazione (1 anno)
859.63%
Paese
US
Scambia Damora Therapeutics, Inc. (DMRA)

Categoria

Healthcare
Rapporto P/S per Damora Therapeutics, Inc. (DMRA)
Rapporto P/S al 2026 TTM: 0
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Damora Therapeutics, Inc., il rapporto P/S attuale (TTM) è 0. Alla fine del 2026, era pari a 0.
Storico del rapporto P/S per Damora Therapeutics, Inc. da 2026 a 2026
Rapporto P/S alla fine di ogni anno
Anno Rapporto P/S Cambia
Non abbastanza dati per le date fornite.
Rapporto P/S per aziende simili o concorrenti
Azienda Rapporto P/S Differenza del rapporto P/S Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.17 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.13 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
2.95 -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
11.28 -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH